Literature DB >> 11679913

Human cytomegalovirus strain Toledo lacks a virus-encoded tropism factor required for infection of aortic endothelial cells.

C Bolovan-Fritts1, J A Wiedeman.   

Abstract

Human cytomegalovirus (HCMV) strains were investigated to identify those with altered tropism for endothelial cells. In viral replication kinetics analysis, HCMV strain Toledo replicated poorly in aortic endothelial cells (AECs), and the virus count was reduced by 2-3 log units, in comparison with strain AD169. Virus entry at the cell surface for each strain was equivalent. However, immunofluorescence studies revealed a lack of immediate early viral antigen 72 expression, and direct blot hybridization failed to detect viral genomes in the nucleus of Toledo-infected AECs. Complementation assays were done to determine whether endothelial cell infectivity was dependent on a virus-encoded tropism factor. Pseudotype virus in endothelial cell cultures indicated that AD169 could provide trans factors to rescue Toledo during infection of endothelial cells. Collectively, these results show that a viral function provides an endothelial cell tropism factor for HCMV and plays a role during postentry infection events.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11679913     DOI: 10.1086/324010

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

Review 1.  Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal.

Authors:  Michael A Jarvis; Jay A Nelson
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

2.  Human cytomegalovirus UL130 protein promotes endothelial cell infection through a producer cell modification of the virion.

Authors:  Marco Patrone; Massimiliano Secchi; Loretta Fiorina; Mariagrazia Ierardi; Gabriele Milanesi; Andrea Gallina
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Human cytomegalovirus increases HUVEC sensitivity to thrombin and modulates expression of thrombin receptors.

Authors:  Milan Popović; Svetlana Paskas; Maja Zivković; Ladislav Burysek; Yves Laumonnier
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

4.  Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.

Authors:  Thomas J Gardner; Cynthia Bolovan-Fritts; Melissa W Teng; Veronika Redmann; Thomas A Kraus; Rhoda Sperling; Thomas Moran; William Britt; Leor S Weinberger; Domenico Tortorella
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

5.  Microtubule network facilitates nuclear targeting of human cytomegalovirus capsid.

Authors:  K Ogawa-Goto; K Tanaka; W Gibson; E Moriishi; Y Miura; T Kurata; S Irie; T Sata
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  An endothelial cell-specific requirement for the UL133-UL138 locus of human cytomegalovirus for efficient virus maturation.

Authors:  Farah Bughio; David A Elliott; Felicia Goodrum
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

7.  Enhanced cytomegalovirus infection in atherosclerotic human blood vessels.

Authors:  Pamela L Nerheim; Jeffery L Meier; Mohammad A Vasef; Wei-Gen Li; Ling Hu; James B Rice; Daniel Gavrila; Wayne E Richenbacher; Neal L Weintraub
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

8.  Cytomegalovirus UL131-128 products promote gB conformational transition and gB-gH interaction during entry into endothelial cells.

Authors:  Marco Patrone; Massimiliano Secchi; Eleonora Bonaparte; Gabriele Milanesi; Andrea Gallina
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

9.  An endogenous accelerator for viral gene expression confers a fitness advantage.

Authors:  Melissa W Teng; Cynthia Bolovan-Fritts; Roy D Dar; Andrew Womack; Michael L Simpson; Thomas Shenk; Leor S Weinberger
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.